Julia G. Butchko, Chief Development Officer at Immunovant, Inc. (IMVT), sold 1,527 shares at $28.06 ($43K) on 2024-07-09, disclosed to the SEC on 2024-07-10.
Open-market sale of $43k IMVT by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IMVT | SELL | 2024-05-24 | $193K | — | Filing → |
| IMVT | SELL | 2024-04-19 | $362K | — | Filing → |
| IMVT | SELL | 2024-04-10 | $33K | — | Filing → |